SGLT2 and GLP-1R — Drug Target

All drugs that target SGLT2 and GLP-1R — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

SGLT2 inhibitor / GLP-1 receptor agonist combination

Marketed (1)

• SGLT2 inhibitor, GLP-1 RA · Brigham and Women's Hospital · SGLT2 inhibitor / GLP-1 receptor agonist combination · Diabetes, Cardiovascular
  This dual-action drug combines SGLT2 inhibition (reducing glucose reabsorption in the kidney) with GLP-1 receptor agonism (enhancing insulin secretion and satiety) to lower blood glucose and body weight.